🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical investigation is to evaluate whether the Hydruste...
Status
Recruiting
Location
Unidade Local de Saúde da Região de Aveiro (ULSRA), E.P.E.
Start Date
2025-09-09
Trial ID
NCT06719089
Treatments Being Tested
Prospective, multi-center 1:1 randomized trial to compare efficacy and safe...
Status
Active Not Recruiting
Location
University Clinic Leipzig
Start Date
2019-01-01
Trial ID
NCT03776799
Treatments Being Tested
The Xen-45 gelatin microstent is a novel, bleb-forming microinvasive glauco...
Status
Completed
Location
Prism Eye Institute
Start Date
2019-06-25
Trial ID
NCT04454138
Treatments Being Tested
This is a prospective, multi-center, non-randomized, single arm clinical tr...
Status
Completed
Location
Bakersfield Memorial Hospital
Start Date
2013-08-21
Trial ID
NCT01925794
Treatments Being Tested
This is a Prospective, Open-label, Multicenter, and Non-randomized Clinical...
Status
Unknown
Location
Centre Hospitalier Universitaire Sherbrooke
Start Date
2019-12-11
Trial ID
NCT04220177
Treatments Being Tested
Phase one of this study is a prospective, randomized (2:1), pilot study tha...
Status
Terminated
Location
Satakunta Central Hospital
Start Date
2014-06
Trial ID
NCT02224235
Treatments Being Tested
The study is a multi-center, voluntary observational study on an ambispecti...
Status
Recruiting
Location
IRCCS San Raffaele Hospital
Start Date
2026-04-28
Trial ID
NCT07096388
Treatments Being Tested
A prospective, multicenter, randomized controlled, open-label, blinded outc...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-03-15
Trial ID
NCT06702657
Treatments Being Tested
Background: exocrine pancreatic insufficiency (IPE), frequent in patients w...
Status
Unknown
Location
Daniel de la Iglesia
Start Date
2022-01-25
Trial ID
NCT05244174
Treatments Being Tested